Latin America Psoriasis Drugs Market Size & Outlook
Related Markets
Latin America psoriasis drugs market highlights
- The Latin America psoriasis drugs market generated a revenue of USD 979.8 million in 2024.
- The market is expected to grow at a CAGR of 12.3% from 2025 to 2030.
- In terms of segment, tumor necrosis factor inhibitors was the largest revenue generating class in 2024.
- InterleU.S.in Inhibitors is the most lucrative class segment registering the fastest growth during the forecast period.
- Country-wise, Argentina is expected to register the highest CAGR from 2025 to 2030.
Latin America data book summary
| Market revenue in 2024 | USD 979.8 million |
| Market revenue in 2030 | USD 1,948.7 million |
| Growth rate | 12.3% (CAGR from 2025 to 2030) |
| Largest segment | Tumor necrosis factor inhibitors |
| Fastest growing segment | InterleU.S.in Inhibitors |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Tumor Necrosis Factor Inhibitors, InterleU.S.in Inhibitors, Vitamin-D Analogues, Corticosteriods |
Other key industry trends
- In terms of revenue, Latin America region accounted for 4.6% of the global psoriasis drugs market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 10,851.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Psoriasis Drugs Market Scope
Psoriasis Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim International GmbH | View profile | - | - | - |
| Celgene Corporation | View profile | - | - | - |
| Eli Lilly and Company | View profile | - | - | - |
| Johnson & Johnson Services, Inc. | View profile | - | - | - |
| Novartis AG | View profile | - | - | - |
| AstraZeneca PLC | View profile | 89900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | https://www.astrazeneca.com |
| UCB SA | View profile | 9083 | Allee de la Recherche, 60, Brussels, Belgium, B-1070 | https://www.ucb.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Amgen Inc | View profile | 26700 | One Amgen Center Drive, Thousand Oaks, CA, United States, 91320-1799 | https://www.amgen.com |
Latin America psoriasis drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to psoriasis drugs market will help companies and investors design strategic landscapes.
Tumor necrosis factor inhibitors was the largest segment with a revenue share of 45.42% in 2024. Horizon Databook has segmented the Latin America psoriasis drugs market based on tumor necrosis factor inhibitors, interleu.s.in inhibitors, vitamin-d analogues, corticosteriods covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Latin America psoriasis drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America psoriasis drugs market databook
-
Our clientele includes a mix of psoriasis drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America psoriasis drugs market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America psoriasis drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America psoriasis drugs market size, by country, 2018-2030 (US$M)
Latin America Psoriasis Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
